[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353586-105":59,"doc-detail-353586-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","synthesis-of-folic-acid-functionalized-hybrid-mesoporous-silica-nanoparticles-and-in-vitro-evaluation-on-mcf-7-breast-cancer-cells","Synthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells","","Folate receptor alpha is expressed at low levels in normal tissues but is elevated in aggressive breast cancer, enabling targeted nanoparticle delivery. A hybrid nanocarrier was prepared from mesoporous silica nanoparticles (MSNs) synthesized in-house, followed by lipid coating and folic acid reinforcement. Physicochemical characterization used DLS, PXRD, TGA, and nitrogen physisorption, while doxorubicin dissolution and release were tested at pH 7.4 and pH 5.5. Cellular uptake and cytotoxicity in MCF-7 cells were assessed by MTT, fluorescence, and microscopy, with cardiotoxicity evaluation on H9c2.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/synthesis-of-folic-acid-functionalized-hybrid-mesoporous-silica-nanoparticles-and-in-vitro-evaluation-on-mcf-7-breast-cancer-cells/353586/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/synthesis-of-folic-acid-functionalized-hybrid-mesoporous-silica-nanoparticles-and-in-vitro-evaluation-on-mcf-7-breast-cancer-cells/353586.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why use folic acid functionalization for breast cancer nanoparticle delivery?","Question",{"text":113,"@type":114},"Folate receptor alpha is overexpressed in aggressive breast cancer subtypes, allowing receptor-mediated endocytosis. This supports efficient internalization of folate-conjugated nanoparticles into target cells and can improve therapeutic delivery.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the hybrid mesoporous silica nanoparticles (MSNs) characterized and optimized?",{"text":118,"@type":114},"The study performed dynamic light scattering (DLS), powder x-ray diffraction (PXRD), thermogravimetric analysis (TGA), and nitrogen physisorption. These methods evaluated size-related properties, structural features, thermal behavior, and porosity.",{"name":120,"@type":111,"acceptedAnswer":121},"What experimental assays were used to evaluate drug release and cellular effects?",{"text":122,"@type":114},"Doxorubicin dissolution was tested in release media at pH 7.4 and pH 5.5. Cytotoxicity and uptake in MCF-7 cells were examined using the MTT assay, doxorubicin fluorescence measurement, and microscopy, and cardiotoxic potential was evaluated in H9c2 cells in vitro.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353586,1790211921,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \nSynthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells  \nMarta Slavkova 1, *,†, Yordan Yordanov 2,†, Christina Voycheva 1, Teodora Popova 1, Ivanka Spassova 3, Daniela Kovacheva 3, Virginia Tzankova 2 and Borislav Tzankov 1, *  \nAcademic Editors: Achim Aigner and Filippo Rossi  \nReceived: 9 November 2025  \nRevised: 10 December 2025  \nAccepted: 19 January 2026  \nPublished: 22 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria; hvoycheva@pharmfac.mu-sofia.bg (C.V.); tpopova@pharmfac.mu-sofia.bg (T.P.)  \n2 Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria; yyordanov@pharmfac.mu-sofia.bg (Y.Y.); vtzankova@pharmfac.mu-sofia.bg (V.T.)  \n3 Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria; [ispasova@svr.igic.bas.bg](ispasova@svr.igic.bas.bg) (I.S.); [didka@svr.igic.bas.bg](didka@svr.igic.bas.bg) (D.K.)  \n* Correspondence: mslavkova@pharmfac.mu-sofia.bg (M.S.); btzankov@pharmfac.mu-sofia.bg (B.T.)† These authors contributed equally to this work.  \nAbstract  \nFolate receptor alpha is expressed at low levels in normal tissues, but is elevated in aggressive breast cancer types and can be utilized for targeted nanoparticle delivery. Hence, we prepared a hybrid nanocarrier based on in-house synthesized mesoporous silica nanoparticles (MSNs) which were further lipid-coated and reinforced with folic acid (FA) . Thorough physicochemical evaluation was performed including dynamic light scattering (DLS), powder x-ray diffraction (PXRD), thermogravimetric analysis (TGA), and nitrogen physisorption. In vitro dissolution of the model drug doxorubicin was carried out in release media with pH 7.4 and pH 5.5 . The cytotoxic potential and cellular uptake were investigated in MCF-7 breast cancer cells via the MTT assay, doxorubicin fluorescence measurement, and microscopy. The potential amelioration of doxorubicin’s cardiotoxicity was evaluated in vitro on the H9c2 cell line. The results showed MSNs with significant pore volume (1.38 cm3 /g) and relatively small sizes (98.05 ± 1.34 nm) . The lipid coat and FA attachment improved the physicochemical stability and sustained release pattern over 24 h. MSNs were non-toxic, while when doxorubicin-loaded, they caused moderate cytotoxicity. The highest cytotoxic activity was observed with folate-functionalized, doxorubicin-loaded nanoparticles (NPs) . Even though non-loaded folate-functionalized NPs exhibited significant cytotoxicity, their physical mixture with doxorubicin was inferior in MCF-7 cytotoxicityas opposed to the corresponding loaded nanocarrier. Fluorescence-based quantification showed a higher intracellular accumulation of doxorubicin when delivered via NPs. These results demonstrate the potential to use folate-functionalized NPs as carriers for doxorubicin delivery in breast cancer cells. Its cardiotoxicity was significantly reduced in the case of loading onto the folic acid-functionalized lipid-coated MSNs. All these findings provide a promising proof-of-concept, although further experimental validation, particularly regarding targeting selectivity and safety, is required.  \nKeywords: doxorubicin; breast cancer; folate targeting; lipid coating; mesoporous silica nanoparticles; hybrid nanoparticles; cardiotoxicity  \n1. Introduction  \nBreast cancer is the most commonly diagnosed cancer in women and accounts for about 30% of all cancer cases [1] . However, most therapeutic modalities have significant side effects and new, more selective therapies are actively researched [2] . Folate rec","cbCaiq36W84Cd3RB","https://ap.wps.com/l/cbCaiq36W84Cd3RB","pdf",8263188,23,"English","# Introduction\n## Folate receptor alpha and targeted delivery\n## Nanocarriers in cancer diagnosis and therapy\n## Passive targeting via EPR effect\n## Active targeting via ligand-receptor interactions","[{\"question\":\"Why use folic acid functionalization for breast cancer nanoparticle delivery?\",\"answer\":\"Folate receptor alpha is overexpressed in aggressive breast cancer subtypes, allowing receptor-mediated endocytosis. This supports efficient internalization of folate-conjugated nanoparticles into target cells and can improve therapeutic delivery.\"},{\"question\":\"How were the hybrid mesoporous silica nanoparticles (MSNs) characterized and optimized?\",\"answer\":\"The study performed dynamic light scattering (DLS), powder x-ray diffraction (PXRD), thermogravimetric analysis (TGA), and nitrogen physisorption. These methods evaluated size-related properties, structural features, thermal behavior, and porosity.\"},{\"question\":\"What experimental assays were used to evaluate drug release and cellular effects?\",\"answer\":\"Doxorubicin dissolution was tested in release media at pH 7.4 and pH 5.5. Cytotoxicity and uptake in MCF-7 cells were examined using the MTT assay, doxorubicin fluorescence measurement, and microscopy, and cardiotoxic potential was evaluated in H9c2 cells in vitro.\"}]","Synthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells | PDF",1790106177,58,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fb4ca0846d17c08fe253863b977d149.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1c0df0a11c2406338b34c6957afb980.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d70b7145ed44e925272401bd808ebca.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35b1d3e6028654b69c02cccddff98728.webp",980,1385]